Contrast agents for cardiovascular imaging are used to enhance the capability of MRI and MRA. Since the advent of the first commercially available MR contrast agent (Gd-DTPA) at the end of the 1980s, investigators have made many advances in contrast-enhanced cardiovascular imaging, most importantly in the detection and characterization of ischemic myocardial injuries and vascular stenosis.
Pier Lucio AnelliVito LorussoFabio Tedoldi